3 results about "Lanthionine" patented technology

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

The invention belongs to the technical field of pet nutritional and functional food processing, and particularly relates to a pet dog epidermis-hair follicle synergistic repair daily ration and a preparation method thereof. The daily ration comprises phytosphingosine, N-stearoyl-L-serine, cholesterol, L-lantidine and epsilon-(gamma-glutamyl)-lysine according to a specific proportion, and the phytosphingosine, the N-stearoyl-L-serine and the cholesterol, the L-lantidine and the epsilon-(gamma-glutamyl)-lysine are respectively used as a cuticle lipid reconstruction precursor and a hair keratin directional cross-linking enhancer. The preparation method comprises the following steps: microencapsulating a lipid precursor, mixing the microencapsulated lipid precursor with a cross-linking agent solution and a basic ration, and instantaneously injecting steam at 105-110 DEG C at 48-52 DEG C by adopting a low-temperature pulse granulation process for forming. According to the method, the activity of thermosensitive components can be protected to the maximum extent, the two functional components can synergistically play the roles of repairing skin barriers and strengthening hair structures in vivo, the water content of the skin of the pet dogs is remarkably increased, water loss is reduced, and the breaking strength and luster of hair are enhanced.

The purpose of the present invention is to provide a novel TRPA1 agonist. The present invention relates to a composition for activating TRPA1, comprising a mushroom extract or lanthionine. The composition can enhance appetite and food consumption and ameliorate decreased appetite.